Hepatitis with cholestasis caused by rivastigmine transdermal patch

American Journal of Gastroenterology

Volumn 104, Issue 11, 2009, Pages 2859-2860

  Mumoli, Nicola ^a   Carmignani, Giovanni ^a   Luschi, Riccardo ^a   Cei, Marco ^a   Chiavistelli, Patrizio ^a  

^a Livorno Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CIMETIDINE; DONEPEZIL; GALANTAMINE; RAMIPRIL; RIVASTIGMINE; TACRINE; THEOPHYLLINE; VALPROIC ACID;

AGED; ALZHEIMER DISEASE; BLOATING; CASE REPORT; CHOLESTASIS; DRUG WITHDRAWAL; FATIGUE; FEMALE; HEPATITIS; HUMAN; JAUNDICE; LETTER; LIVER CELL DAMAGE; LIVER TOXICITY; LOW DRUG DOSE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RISK REDUCTION; TRANSDERMAL PATCH; WEAKNESS;

AGED, 80 AND OVER; ALZHEIMER DISEASE; CHOLESTASIS; CHOLINESTERASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG-INDUCED LIVER INJURY; FEMALE; FOLLOW-UP STUDIES; HUMANS; PHENYLCARBAMATES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; WITHHOLDING TREATMENT;

EID: 72049131568     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2009.373     Document Type: Letter

References (5)

1. Raina P, Santaguida P, Ismaila A et al. Eff ectiveness of cholinesterase inhibitors and memantine for treating dementia: evidence review for a clinical practice guideline. Ann Intern Med 2008;148:379-397 (Pubitemid 351665469)
2. Lefèvre G, Sedek G, Jhee SS et al. Pharmacokinetics and pharmacodynamics of the novel daily rivastigmine transdermal patch compared with twice-daily capsules in Alzheimer's disease patients. Clin Pharmacol Th er 2008;83:106-114
3. Cummings J, Lefèvre G, Small G et al. Pharmacokinetic rationale for the rivastigmine patch. Neurology 2007;69 (4 Suppl 1):S10-3.
4. Nordberg A, Svensson AL. Cholinesterase inhibitors in the treatment of Alzheimer's disease: a comparison of tolerability and pharmacology. Drug Saf 1998;19:465-480 (Pubitemid 29015406)
5. Naranjo CA, Busto U, Sellers EM et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Th er 1981;30:239-245 (Pubitemid 11140804)